Clinical Trials Browser

Extensive Stage Small Cell Lung Cancer (ES-SCLC) × Clear all

NCT07425795 2026-02-23

Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer

Phase 2 Recruiting

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT06853678 2025-03-03

Second-line Immunotherapy for ES-SCLC

Phase NA Recruiting

Extensive Stage Small Cell Lung Cancer (ES-SCLC)